Healthcare Industry News: stereotactic radiation therapy
News Release - November 6, 2006
Elekta and IMPAC Users at ASTRO Discuss How Technology Advancements for Cancer Management are Shaping Clinical PracticeATLANTA and PHILADELPHIA, Nov. 6 (HSMN NewsFeed) -- Approximately 1,500 Elekta and IMPAC customers convened in Philadelphia, Pa., November 4, 2006, at the 48th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting to advance their clinical confidence in implementing image guided radiation therapy (IGRT) and image guided treatment management (IGTM(TM)) solutions. Elekta and IMPAC Medical Systems, an Elekta company, provide a portfolio of products that spans the entire spectrum of cancer management and which empowers clinicians to improve their patients' treatment. Elekta's IGRT and IGTM solutions position the company as a leader in the rapidly evolving radiation oncology industry.
"The Users Meeting for 2006, in particular, was a resounding success - combining a focus on advanced technology with an appreciation of how emerging trends are shaping how clinicians manage their patients' treatment," says Tomas Puusepp, President and CEO of Elekta. "The SYNERGISTIQ(TM) workspace is a great example of that, reducing the need for multiple workstations and streamlining the IGTM delivery solution to eliminate confusion and speed treatment planning and delivery."
The Users Meeting featured more than 50 informative sessions by renowned clinicians, who are among the pioneers of IGRT and IGTM in the clinical arena. Several tours of Temple University Cancer Center gave participants a hands-on perspective of Empowered Oncology, an Elekta solution that emphasizes how IGRT and IGTM technology can arm physicians with powerful technological weapons in the fight against serious disease.
"Because image guided treatment systems represent a revolutionary technological leap in technology, they are driving clinical centers to rethink their technology strategies," Puusepp adds. "Elekta is proud to lead this revolution. Our IGRT offerings, such as Elekta Synergy®, make radiation delivery more precise, providing a more effective treatment without additional risk. In addition, IMPAC is the leader in IGTM, which manages the entire IGRT workflow. Together, Elekta and IMPAC solutions elevate precision, efficiency and efficacy to unprecedented levels."
The solutions behind Empowered Oncology
Elekta and IMPAC are helping empower clinicians to fight serious disease with a formidable array of technological solutions.
Elekta Synergy® -- The reference system for IGRT
Elekta Synergy gives physicians the power to treat patients with a multifunctional linear accelerator that - via advanced integrated 3D cone beam imaging technology - enables visualization of targets, critical organs and soft tissues at the time of treatment. Elekta Synergy features full multifunctional capability that is fully upgradeable to permit hypofractionation and SRS.
Elekta Axesse® -- The ultimate whole body stereotactic system
Elekta Axesse provides the power to treat targets more aggressively than ever with the most accurate and efficient stereotactic system available. The system enables 6D (x, y, z, roll, pitch, yaw) robotic image guided stereotactic radiation therapy, a breakthrough in system accuracy and flexibility.
Leksell Gamma Knife® Perfexion(TM) -- A revolution in stereotactic radiosurgery
With Leksell Gamma Knife Perfexion, physicians have the power to deliver fully automated single-button treatment with the world's most proven dedicated stereotactic radiosurgery system. This system affords unmatched accuracy and precision for radiosurgery, delivering sophisticated treatment plans in significantly less time.
MOSAIQ(TM) -- Image-enabled Electronic Medical Record
With MOSAIQ(TM), from IMPAC, doctors will have the power to access vital information anywhere and anytime, uniting diverse systems and providing a more intelligent process management solution. MOSAIQ provides a comprehensive oncology charting solution with features that track patients from the moment they enter the cancer center through long-term follow-up.
Service - the foundation of Empowered Oncology
Elekta supports its marketing-leading technology with a service team dedicated to offering the best customer experience and the highest reliability.
"We can empower physicians with the most state-of-the-art tools to manage serious disease, but without world-class service, uptime can become an issue," says Anthony DeCarolis, president and CEO of Elekta and head of Elekta's operations in North America. "With strategically deployed service technicians plus an advanced logistics network, Elekta guarantees uptime."
Elekta is an international medical-technology group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 2,000 employees, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.